Daily Biotech Executive Brief
By Sturnbridge Technology Consulting
Categories: Technology
The Biotech Executive Brief is a daily podcast covering the developments shaping artificial intelligence, pharma and life sciences, and the broader business landscape. Each episode highlights the news executives should have on their radar—from AI and emerging technology to clinical results, FDA decisions, biotech financing, M&A, manufacturing, earnings and major business developments. Stay informed with The Biotech Executive Brief, produced by Sturnbridge Technology Consulting
13 episodes indexed on PodSearch.
Recent episodes
- Biotech Executive Brief — November 16, 2026
The November 16th edition of the Biotech Executive Brief examines California's lawsuit against OpenAI, international efforts to protect AI infrastructure, and the Federal Reserve's assessment of AI's economic implications. In Pharma and Life Sciences, Johnson & Johnson acquires Ollin Biosciences…
- Biotech Executive Brief — November 15, 2026
This weekend’s Biotech Executive Brief covers OpenAI’s ChatGPT Wallet, Anthropic’s IPO outlook, AI cybersecurity policy, Summit Therapeutics’ FDA setback, Regeneron’s POTS data, AstraZeneca’s bladder cancer approval, biotech financing, European market flows and U.S. aviation infrastructure…
- Biotech Executive Brief — November 12, 2026
Biotech Executive Brief | November 12, 2026 Today's episode examines Cerebras' accelerating AI infrastructure business, Eli Lilly's oral obesity-drug approval in China, Bristol Myers Squibb's R&D reorganization, questions surrounding the FDA's priority voucher pilot, Applied Materials' record…
- Tuesday, September 1st 2026
The Biotech Executive Brief for Tuesday, September 1, 2026 covers a busy start to the month across artificial intelligence, pharma and life sciences, and major business news. OpenAI disclosed that its forthcoming Astra model has reached a critical cybersecurity capability threshold, Anthropic…
- Monday, August 31st 2026
The Biotech Executive Brief for Monday, August 31, 2026 covers a particularly active day across artificial intelligence, pharma and life sciences, and major business news. Nvidia invested $3.5 billion in MediaTek, Anthropic signed a $35 billion cloud-computing agreement with Lambda, Eli Lilly…
- Friday, August 28th 2026
The Biotech Executive Brief for Friday, August 28, 2026 covers another active day across artificial intelligence, pharma and life sciences, and major business news. A federal judge blocked the Pentagon’s blacklisting of Anthropic, the FDA expanded Eli Lilly’s Mounjaro label to include…
- Thursday, August 27th 2026
The Biotech Executive Brief for Thursday, August 27, 2026 covers a major day across artificial intelligence, pharma and life sciences, and the broader business environment. Nvidia reportedly agreed to acquire Hugging Face for $12.9 billion, Anthropic explored a multibillion-dollar AI-chip…
- Wednesday, August 26 2026
The Biotech Executive Brief for Wednesday, August 26, 2026 covers a major day across artificial intelligence, pharma and life sciences, and the broader business landscape. Nvidia reported $96.22 billion in quarterly revenue and raised its outlook, investigations revealed new details about OpenAI…
- Tuesday, August 25 2026
The Biotech Executive Brief for Tuesday, August 25, 2026 covers another active day across artificial intelligence, pharma and life sciences, and major business news. OpenAI released the first benchmarks for its custom Jalapeño inference chip, Google expanded Gemini Enterprise into legal workflows…
- Monday August 24 2026
In this episode of The Biotech Executive Brief, we cover the developments shaping AI, pharma and life sciences, and the broader business landscape for Monday, August 24, 2026.In AI, Alibaba launches its Wan3.0 video-generation model immediately following a roughly $10.2 billion capital raise…
- Friday Aug 21 - Aug 23: Weekend Wrap-Up
The Biotech Executive Brief covering Friday, August 21 through Sunday, August 23, 2026 looks at the major developments across artificial intelligence, pharma and life sciences, and the broader business environment. AI infrastructure financing and pricing remained in focus as Nvidia invested in…
- Biotech Executive Brief: Thursday August 20th 2026
The Biotech Executive Brief for Thursday, August 20, 2026 covers another significant day across artificial intelligence, pharma and life sciences, and major business news. Alibaba's AI infrastructure investments weighed heavily on profit, Broadcom was reported to be seeking more than $60 billion…
- Biotech Executive Brief: August 19 2026
The Biotech Executive Brief for Wednesday, August 19, 2026 covers a major day across artificial intelligence, pharma and life sciences, and the broader business landscape. Google deepened its AI-chip strategy through a major Marvell partnership, Moderna and Merck reported pivotal melanoma vaccine…
PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.